64 related articles for article (PubMed ID: 23601351)
1. Neutron contamination in radiotherapy: estimation of second cancers based on measurements in 1377 patients.
Expósito MR; Sánchez-Nieto B; Terrón JA; Domingo C; Gómez F; Sánchez-Doblado F
Radiother Oncol; 2013 May; 107(2):234-41. PubMed ID: 23601351
[TBL] [Abstract][Full Text] [Related]
2. Estimation of neutron-equivalent dose in organs of patients undergoing radiotherapy by the use of a novel online digital detector.
Sánchez-Doblado F; Domingo C; Gómez F; Sánchez-Nieto B; Muñiz JL; García-Fusté MJ; Expósito MR; Barquero R; Hartmann G; Terrón JA; Pena J; Méndez R; Gutiérrez F; Guerre FX; Roselló J; Núñez L; Brualla-González L; Manchado F; Lorente A; Gallego E; Capote R; Planes D; Lagares JI; González-Soto X; Sansaloni F; Colmenares R; Amgarou K; Morales E; Bedogni R; Cano JP; Fernández F
Phys Med Biol; 2012 Oct; 57(19):6167-91. PubMed ID: 22971664
[TBL] [Abstract][Full Text] [Related]
3. Commissioning the neutron production of a Linac: development of a simple tool for second cancer risk estimation.
Romero-Expósito M; Sánchez-Nieto B; Terrón JA; Lopes MC; Ferreira BC; Grishchuk D; Sandín C; Moral-Sánchez S; Melchor M; Domingo C; Gómez F; Sánchez-Doblado F
Med Phys; 2015 Jan; 42(1):276-81. PubMed ID: 25563267
[TBL] [Abstract][Full Text] [Related]
4. A new online detector for estimation of peripheral neutron equivalent dose in organ.
Irazola L; Lorenzoli M; Bedogni R; Pola A; Terrón JA; Sanchez-Nieto B; Expósito MR; Lagares JI; Sansaloni F; Sanchez-Doblado F
Med Phys; 2014 Nov; 41(11):112105. PubMed ID: 25370656
[TBL] [Abstract][Full Text] [Related]
5. Risk of developing second cancer from neutron dose in proton therapy as function of field characteristics, organ, and patient age.
Zacharatou Jarlskog C; Paganetti H
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):228-35. PubMed ID: 18571337
[TBL] [Abstract][Full Text] [Related]
6. Out-of-field neutron and leakage photon exposures and the associated risk of second cancers in high-energy photon radiotherapy: current status.
Takam R; Bezak E; Marcu LG; Yeoh E
Radiat Res; 2011 Oct; 176(4):508-20. PubMed ID: 21756083
[TBL] [Abstract][Full Text] [Related]
7. Semi-experimental assessment of neutron equivalent dose and secondary cancer risk for off-field organs in glioma patients undergoing 18-MV radiotherapy.
Elmtalab S; Abedi I; Alirezaei Z; Choopan Dastjerdi MH; Geraily G; Karimi AH
PLoS One; 2022; 17(7):e0271028. PubMed ID: 35905102
[TBL] [Abstract][Full Text] [Related]
8. Dosimetry of clinical neutron and proton beams: an overview of recommendations.
Vynckier S; ;
Radiat Prot Dosimetry; 2004; 110(1-4):565-72. PubMed ID: 15353710
[TBL] [Abstract][Full Text] [Related]
9. Secondary neutron doses for several beam configurations for proton therapy.
Shin D; Yoon M; Kwak J; Shin J; Lee SB; Park SY; Park S; Kim DY; Cho KH
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):260-5. PubMed ID: 19362245
[TBL] [Abstract][Full Text] [Related]
10. Experimental study of the influence of dental restorations on thermal and fast photo-neutron production in radiotherapy with a high-energy photon beam.
Ghorbani M; Azizi M; Mowlavi AA; Azadegan B
Appl Radiat Isot; 2019 May; 147():113-120. PubMed ID: 30870764
[TBL] [Abstract][Full Text] [Related]
11. The risk of second primary cancers due to peripheral photon and neutron doses received during prostate cancer external beam radiation therapy.
Bezak E; Takam R; Yeoh E; Marcu LG
Phys Med; 2017 Oct; 42():253-258. PubMed ID: 28302493
[TBL] [Abstract][Full Text] [Related]
12. Special radiobiological features of second cancer risk after particle radiotherapy.
Trott KR
Phys Med; 2017 Oct; 42():221-227. PubMed ID: 29103987
[TBL] [Abstract][Full Text] [Related]
13. Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy.
Kry SF; Salehpour M; Followill DS; Stovall M; Kuban DA; White RA; Rosen II
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1204-16. PubMed ID: 15990026
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the neutron contamination in IMRT deliveries with a paired magnesium and boron coated magnesium ionization chamber system.
Becker J; Brunckhorst E; Schmidt R
Radiother Oncol; 2008 Feb; 86(2):182-6. PubMed ID: 18023490
[TBL] [Abstract][Full Text] [Related]
15. Comparison of whole-body phantom designs to estimate organ equivalent neutron doses for secondary cancer risk assessment in proton therapy.
Moteabbed M; Geyer A; Drenkhahn R; Bolch WE; Paganetti H
Phys Med Biol; 2012 Jan; 57(2):499-515. PubMed ID: 22217682
[TBL] [Abstract][Full Text] [Related]
16. Monte Carlo estimation of photoneutrons contamination from high-energy X-ray medical accelerators in treatment room and maze: a simplified model.
Zabihzadeh M; Ay MR; Allahverdi M; Mesbahi A; Mahdavi SR; Shahriari M
Radiat Prot Dosimetry; 2009 Jul; 135(1):21-32. PubMed ID: 19483207
[TBL] [Abstract][Full Text] [Related]
17. Measurement of neutron dose equivalent and its dependence on beam configuration for a passive scattering proton delivery system.
Wang X; Sahoo N; Zhu RX; Zullo JR; Gillin MT
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1563-70. PubMed ID: 20097484
[TBL] [Abstract][Full Text] [Related]
18. Analytic estimates of secondary neutron dose in proton therapy.
Anferov V
Phys Med Biol; 2010 Dec; 55(24):7509-22. PubMed ID: 21098918
[TBL] [Abstract][Full Text] [Related]
19. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma.
Brodin NP; Munck Af Rosenschöld P; Aznar MC; Kiil-Berthelsen A; Vogelius IR; Nilsson P; Lannering B; Björk-Eriksson T
Acta Oncol; 2011 Aug; 50(6):806-16. PubMed ID: 21767178
[TBL] [Abstract][Full Text] [Related]
20. Peripheral equivalent neutron dose model implementation for radiotherapy patients.
Irazola L; Terrón JA; Sánchez-Nieto B; Roberto B; Sánchez-Doblado F
Phys Med; 2017 Oct; 42():345-352. PubMed ID: 28372877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
